5.40 3 years ago you bagholders are all happy its still a 1.94 big deal, many bought over 3 and are still down over 30% so before you toot your horn this stock still needs to make some of those losses back
lucky to get back to 2 this year at this rate. EMA approval we are waiting and when the stock doesnt move the pumpers will say ohhh next quarter, next year, next conference, nest week????? right LOSERS
good news stock is up once cent, really a pathetic POS this stock is. NO MATTER WHAT THEY DO THIS STOCK DOESN['T MOVE Facts are facts
Navidea continues progress in placing Lymphoseek on a global scale but such efforts remain below the radar screen on Wall Street. Always the case with NAVB below wall street radar and below anyone realistic stock price.
each year the stock is lower than before 3 years ago it was 5.40 last year 3.40 this year 1.70, terrible financing arrangements will sink this concordia
that was the bill of goods we were sold. instead we have 140k in revenues, huge debts, more shares outstanding, cash burn 40 million, and 1.73 stock price. What a sham this turned into.
Sentiment: Strong Sell